Trademark: X-MAN 1663808
Word
X-MAN
ID
1663808
Trademark Type
Word
Status
Protected: Renewal due
Application Date
19 August 2014
Registration Date
19 August 2014
Renewal Date
19 August 2024
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 1:
Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes; biological and chemical reagents, including, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use
Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes; biological and chemical reagents, including, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use
Class 5:
Protein cell lysates, genomic DNA preparations and formalin-fixed, paraffin-embedded (FFPE) engineered tumor mimics for diagnostic use
Protein cell lysates, genomic DNA preparations and formalin-fixed, paraffin-embedded (FFPE) engineered tumor mimics for diagnostic use
Class 42:
Custom cell-line engineering services; gene-editing services; DNA modeling services; gene engineering services; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; identification of patient-relevant drug targets; optimisation of drug candidates for clinical development; support services for the medical diagnostic services industry, namely the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines, chemicals and compounds; creating libraries or collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications
Custom cell-line engineering services; gene-editing services; DNA modeling services; gene engineering services; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; identification of patient-relevant drug targets; optimisation of drug candidates for clinical development; support services for the medical diagnostic services industry, namely the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines, chemicals and compounds; creating libraries or collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications